サマリー

消化器疾患治療薬の世界市場 2023-2027
胃腸疾患治療薬市場は2022-2027年に1億7,074億4,000万米ドル成長し、予測期間中のCAGRは6.67%で加速すると予測されます。この調査レポートは、消化器疾患治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、消化器疾患の罹患率の増加、消化器治療薬の新製品上市、生物学的製剤や標的治療薬に対する需要の増加によって牽引されています。
Technavioの消化器疾患治療薬市場は以下のように区分されます：
薬剤クラス別
- 抗炎症薬および免疫抑制薬
- 酸中和剤
- その他
タイプ別
- ブランド
- ジェネリック医薬品
地域別
- 北米
- アジア
- 欧州
- その他の地域（ROW）
本調査では、栄養療法が利用可能であることが、今後数年間の消化器疾患治療薬市場の成長を促進する主な理由の1つであると特定しています。また、微生物ベースの療法の出現や、在宅療法と相まってセルフメディケーションの増加も、市場の大きな需要につながるでしょう。
この調査レポートは、胃腸疾患治療薬市場を調査・分析し、以下のてこ入れを行います：
- 消化器疾患治療薬市場のサイジング
- 消化器疾患治療薬市場予測
- 消化器疾患治療薬市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories社、AbbVie Inc.社、AstraZeneca Plc社、Bausch Health Companies Inc.社、Bayer AG社、Biogen Inc.社、Boehringer Ingelheim International GmbH社、Boston Scientific Corp.社、Eisai Co.エーザイ株式会社、イーライリリー・アンド・カンパニー、Evoke Pharma Inc.、グラクソ・スミスクライン Plc、ジョンソン・エンド・ジョンソン、Merck and Co.Inc.、Novartis AG、Olympus Corp.、Ovesco Endoscopy AG、Pfizer Inc.Ltd.、UCB SAなどである。また、消化器疾患治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gastrointestinal-diseases-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gastrointestinal diseases therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global gastrointestinal diseases therapeutics market 2017 - 2021 ($ million)
o 4.2 Drug class Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027
o Exhibit 34: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
o 6.4 Acid neutralizers - Market size and forecast 2022-2027
o Exhibit 38: Chart on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Acid neutralizers - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Acid neutralizers - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Drug Class
o Exhibit 46: Market opportunity by Drug Class ($ million)
o Exhibit 47: Data Table on Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Branded - Market size and forecast 2022-2027
o Exhibit 52: Chart on Branded - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Branded - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Branded - Year-over-year growth 2022-2027 (%)
o 7.4 Generics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Generics - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Generics - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Generics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Generics - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 60: Market opportunity by Type ($ million)
o Exhibit 61: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Japan - Market size and forecast 2022-2027
o Exhibit 87: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories - Overview
o Exhibit 112: Abbott Laboratories - Business segments
o Exhibit 113: Abbott Laboratories - Key news
o Exhibit 114: Abbott Laboratories - Key offerings
o Exhibit 115: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 116: AbbVie Inc. - Overview
o Exhibit 117: AbbVie Inc. - Product / Service
o Exhibit 118: AbbVie Inc. - Key news
o Exhibit 119: AbbVie Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 120: AstraZeneca Plc - Overview
o Exhibit 121: AstraZeneca Plc - Product / Service
o Exhibit 122: AstraZeneca Plc - Key news
o Exhibit 123: AstraZeneca Plc - Key offerings
o 12.6 Bausch Health Companies Inc.
o Exhibit 124: Bausch Health Companies Inc. - Overview
o Exhibit 125: Bausch Health Companies Inc. - Business segments
o Exhibit 126: Bausch Health Companies Inc. - Key news
o Exhibit 127: Bausch Health Companies Inc. - Key offerings
o Exhibit 128: Bausch Health Companies Inc. - Segment focus
o 12.7 Bayer AG
o Exhibit 129: Bayer AG - Overview
o Exhibit 130: Bayer AG - Business segments
o Exhibit 131: Bayer AG - Key news
o Exhibit 132: Bayer AG - Key offerings
o Exhibit 133: Bayer AG - Segment focus
o 12.8 Biogen Inc.
o Exhibit 134: Biogen Inc. - Overview
o Exhibit 135: Biogen Inc. - Product / Service
o Exhibit 136: Biogen Inc. - Key offerings
o 12.9 Boehringer Ingelheim International GmbH
o Exhibit 137: Boehringer Ingelheim International GmbH - Overview
o Exhibit 138: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 139: Boehringer Ingelheim International GmbH - Key news
o Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus
o 12.10 Boston Scientific Corp.
o Exhibit 142: Boston Scientific Corp. - Overview
o Exhibit 143: Boston Scientific Corp. - Business segments
o Exhibit 144: Boston Scientific Corp. - Key news
o Exhibit 145: Boston Scientific Corp. - Key offerings
o Exhibit 146: Boston Scientific Corp. - Segment focus
o 12.11 Eisai Co. Ltd.
o Exhibit 147: Eisai Co. Ltd. - Overview
o Exhibit 148: Eisai Co. Ltd. - Business segments
o Exhibit 149: Eisai Co. Ltd. - Key offerings
o Exhibit 150: Eisai Co. Ltd. - Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 151: GlaxoSmithKline Plc - Overview
o Exhibit 152: GlaxoSmithKline Plc - Business segments
o Exhibit 153: GlaxoSmithKline Plc - Key news
o Exhibit 154: GlaxoSmithKline Plc - Key offerings
o Exhibit 155: GlaxoSmithKline Plc - Segment focus
o 12.13 Johnson and Johnson
o Exhibit 156: Johnson and Johnson - Overview
o Exhibit 157: Johnson and Johnson - Business segments
o Exhibit 158: Johnson and Johnson - Key news
o Exhibit 159: Johnson and Johnson - Key offerings
o Exhibit 160: Johnson and Johnson - Segment focus
o 12.14 Merck and Co. Inc.
o Exhibit 161: Merck and Co. Inc. - Overview
o Exhibit 162: Merck and Co. Inc. - Business segments
o Exhibit 163: Merck and Co. Inc. - Key news
o Exhibit 164: Merck and Co. Inc. - Key offerings
o Exhibit 165: Merck and Co. Inc. - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 166: Pfizer Inc. - Overview
o Exhibit 167: Pfizer Inc. - Product / Service
o Exhibit 168: Pfizer Inc. - Key news
o Exhibit 169: Pfizer Inc. - Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 UCB SA
o Exhibit 174: UCB SA - Overview
o Exhibit 175: UCB SA - Product / Service
o Exhibit 176: UCB SA - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global gastrointestinal diseases therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Acid neutralizers - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Acid neutralizers - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Drug Class ($ million)
Exhibits47: Data Table on Market opportunity by Drug Class ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Branded - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Branded - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Branded - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Generics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Generics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Generics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Generics - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Type ($ million)
Exhibits61: Data Table on Market opportunity by Type ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories - Overview
Exhibits112: Abbott Laboratories - Business segments
Exhibits113: Abbott Laboratories - Key news
Exhibits114: Abbott Laboratories - Key offerings
Exhibits115: Abbott Laboratories - Segment focus
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key news
Exhibits119: AbbVie Inc. - Key offerings
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bausch Health Companies Inc. - Overview
Exhibits125: Bausch Health Companies Inc. - Business segments
Exhibits126: Bausch Health Companies Inc. - Key news
Exhibits127: Bausch Health Companies Inc. - Key offerings
Exhibits128: Bausch Health Companies Inc. - Segment focus
Exhibits129: Bayer AG - Overview
Exhibits130: Bayer AG - Business segments
Exhibits131: Bayer AG - Key news
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Biogen Inc. - Overview
Exhibits135: Biogen Inc. - Product / Service
Exhibits136: Biogen Inc. - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Overview
Exhibits138: Boehringer Ingelheim International GmbH - Business segments
Exhibits139: Boehringer Ingelheim International GmbH - Key news
Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
Exhibits141: Boehringer Ingelheim International GmbH - Segment focus
Exhibits142: Boston Scientific Corp. - Overview
Exhibits143: Boston Scientific Corp. - Business segments
Exhibits144: Boston Scientific Corp. - Key news
Exhibits145: Boston Scientific Corp. - Key offerings
Exhibits146: Boston Scientific Corp. - Segment focus
Exhibits147: Eisai Co. Ltd. - Overview
Exhibits148: Eisai Co. Ltd. - Business segments
Exhibits149: Eisai Co. Ltd. - Key offerings
Exhibits150: Eisai Co. Ltd. - Segment focus
Exhibits151: GlaxoSmithKline Plc - Overview
Exhibits152: GlaxoSmithKline Plc - Business segments
Exhibits153: GlaxoSmithKline Plc - Key news
Exhibits154: GlaxoSmithKline Plc - Key offerings
Exhibits155: GlaxoSmithKline Plc - Segment focus
Exhibits156: Johnson and Johnson - Overview
Exhibits157: Johnson and Johnson - Business segments
Exhibits158: Johnson and Johnson - Key news
Exhibits159: Johnson and Johnson - Key offerings
Exhibits160: Johnson and Johnson - Segment focus
Exhibits161: Merck and Co. Inc. - Overview
Exhibits162: Merck and Co. Inc. - Business segments
Exhibits163: Merck and Co. Inc. - Key news
Exhibits164: Merck and Co. Inc. - Key offerings
Exhibits165: Merck and Co. Inc. - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits174: UCB SA - Overview
Exhibits175: UCB SA - Product / Service
Exhibits176: UCB SA - Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations